When compared with low-risk patients, high-risk patients were younger (median age 58 versus 63 years), more frequently diagnosed with a lobular tumour (24% versus 14%), and less frequently diagnosed with both an ER+ and PR+ tumour (79% versus 85%; Table 1). The gene discussed is PGR; the disease is neoplasm.